Trial Number
351-23
Conditions
Pediatric Cancer, Brain Tumor
Participant Age Range
3 years to 22 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“A Phase 3 Study of Sodium Thiosulfate for the Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy for Children with Medulloblastoma with Low-Risk Features”
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss.